PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Baillie Gifford Health Innovation Equities Fund (B...
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Fund Info

ISIN

US05682B8515

Issuer

Baillie Gifford Funds

Inception Date

Dec 27, 2021

Min. Investment

$0

Asset Class

Equity

Asset Class Size

Large-Cap

Asset Class Style

Growth

Expense Ratio

BGHBX features an expense ratio of 0.65%, falling within the medium range.


Expense ratio chart for BGHBX: current value at 0.65% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.65%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Baillie Gifford Health Innovation Equities Fund, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%-5.00%0.00%5.00%AugustSeptemberOctoberNovemberDecember2025
-6.83%
3.10%
BGHBX (Baillie Gifford Health Innovation Equities Fund)
Benchmark (^GSPC)

Returns By Period

Baillie Gifford Health Innovation Equities Fund had a return of 0.00% year-to-date (YTD) and -4.66% in the last 12 months.


BGHBX

YTD

0.00%

1M

-0.35%

6M

-6.83%

1Y

-4.66%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-0.66%

1M

-3.44%

6M

3.10%

1Y

22.14%

5Y*

12.04%

10Y*

11.24%

*Annualized

Monthly Returns

The table below presents the monthly returns of BGHBX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-3.20%1.57%3.25%-7.13%1.07%2.65%1.03%2.21%0.67%-3.48%-0.17%-1.55%-3.54%
20235.93%-7.28%2.57%0.44%-2.20%0.30%3.89%-10.94%-9.69%-9.84%7.34%9.80%-11.87%
2022-20.44%-3.40%2.09%-17.24%-2.93%0.79%8.52%0.73%-8.80%5.70%5.84%-4.66%-32.46%
2021-0.20%-0.20%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BGHBX is 6, meaning it’s performing worse than 94% of other mutual funds on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of BGHBX is 66
Overall Rank
The Sharpe Ratio Rank of BGHBX is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of BGHBX is 66
Sortino Ratio Rank
The Omega Ratio Rank of BGHBX is 77
Omega Ratio Rank
The Calmar Ratio Rank of BGHBX is 77
Calmar Ratio Rank
The Martin Ratio Rank of BGHBX is 44
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Baillie Gifford Health Innovation Equities Fund (BGHBX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for BGHBX, currently valued at -0.25, compared to the broader market-1.000.001.002.003.004.00-0.251.74
The chart of Sortino ratio for BGHBX, currently valued at -0.23, compared to the broader market0.002.004.006.008.0010.00-0.232.35
The chart of Omega ratio for BGHBX, currently valued at 0.97, compared to the broader market1.002.003.000.971.32
The chart of Calmar ratio for BGHBX, currently valued at -0.11, compared to the broader market0.005.0010.0015.00-0.112.62
The chart of Martin ratio for BGHBX, currently valued at -1.03, compared to the broader market0.0020.0040.0060.00-1.0310.82
BGHBX
^GSPC

The current Baillie Gifford Health Innovation Equities Fund Sharpe ratio is -0.25. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Baillie Gifford Health Innovation Equities Fund with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
-0.25
1.74
BGHBX (Baillie Gifford Health Innovation Equities Fund)
Benchmark (^GSPC)

Dividends

Dividend History

Baillie Gifford Health Innovation Equities Fund provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%0.00%0.00%0.01%0.01%0.01%$0.00$0.00$0.00$0.00$0.00$0.00202220232024
Dividends
Dividend Yield
PeriodTTM202420232022
Dividend$0.00$0.00$0.00$0.00

Dividend yield

0.00%0.00%0.00%0.01%

Monthly Dividends

The table displays the monthly dividend distributions for Baillie Gifford Health Innovation Equities Fund. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.00
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-42.75%
-4.06%
BGHBX (Baillie Gifford Health Innovation Equities Fund)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Baillie Gifford Health Innovation Equities Fund. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Baillie Gifford Health Innovation Equities Fund was 50.55%, occurring on Oct 27, 2023. The portfolio has not yet recovered.

The current Baillie Gifford Health Innovation Equities Fund drawdown is 42.75%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-50.55%Dec 31, 2021459Oct 27, 2023
-1.5%Dec 29, 20211Dec 29, 20211Dec 30, 20212

Volatility

Volatility Chart

The current Baillie Gifford Health Innovation Equities Fund volatility is 1.43%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%AugustSeptemberOctoberNovemberDecember2025
1.43%
4.57%
BGHBX (Baillie Gifford Health Innovation Equities Fund)
Benchmark (^GSPC)
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab